المؤلفون: M. D. Suprun, P. A. Sholkina, L. A. Semyonova, L. P. Ananyeva

المصدر: Современная ревматология, Vol 18, Iss 1, Pp 76-83 (2024)

مصطلحات موضوعية: rheumatoid arthritis, lung lesions, tuberculoma, methotrexate, rituximab, computed tomography of the lungs, Medicine

وصف الملف: electronic resource

Relation: https://mrj.ima-press.net/mrj/article/view/1535; https://doaj.org/toc/1996-7012; https://doaj.org/toc/2310-158X

URL الوصول: https://doaj.org/article/7bba3b37a7704124b58d1eceacb8ab12

المؤلفون: Iuliano, Mariagrazia, Slater, Marie-Christine, Stolk, Arian J., Weaver, Matthew J., Chakraborty, Tanmoy, Loukiantchenko, Elsie, Amaral, Gustavo Castro do, Alfasi, Nir, Sholkina, Mariya O., Tittel, Wolfgang, Hanson, Ronald

مصطلحات موضوعية: Quantum Physics

URL الوصول: http://arxiv.org/abs/2403.18581

المؤلفون: A. S. Potapova, A. E. Karateev, E. Yu. Polishchuk, P. A. Sholkina, E. S. Filatova, V. N. Amirjanova, A. M. Lila, А. С. Потапова, А. Е. Каратеев, Е. Ю. Полищук, П. А. Шолкина, Е. С. Филатова, В. Н. Амирджанова, А. М. Лила

المساهمون: Работа выполнена в рамках фундаментальной темы (номер государственного задания PK 122040400051-3). Исследование не имело спонсорской поддержки.

المصدر: Rheumatology Science and Practice; Vol 62, No 5 (2024); 535-541 ; Научно-практическая ревматология; Vol 62, No 5 (2024); 535-541 ; 1995-4492 ; 1995-4484

مصطلحات موضوعية: БПВП, including biologic DMARDs or JAKi, удовлетворенность, PASS, центральная сенситизация, CSI, PainDETECT, ГИБП, ингибиторы JAK

وصف الملف: application/pdf

Relation: https://rsp.mediar-press.net/rsp/article/view/3640/2408; Насонов ЕЛ, Олюнин ЮА, Лила АМ. Ревматоидный артрит: проблемы ремиссии и резистентности к терапии. Научно-практическая ревматология. 2018;56(3):263-271.; Smolen JS, Landewé RBM, Bijlsma JWJ, Burmester GR, Dougados M, Kerschbaumer A, et al. EULAR recommendations for the management of rheumatoid arthritis with synthetic and biological disease-modifying antirheumatic drugs: 2019 update. Ann Rheum Dis. 2020;79(6):685-699. doi:10.1136/annrheumdis-2019-216655; Aletaha D. Precision medicine and management of rheumatoid arthritis. J Autoimmun. 2020;110:102405. doi:10.1016/j.jaut.2020.102405; Westerlind H, Glintborg B, Hammer HB, Saevarsdottir S, Krogh NS, Hetland ML, et al. Remission, response, retention and persistence to treatment with disease-modifying agents in patients with rheumatoid arthritis: A study of harmonised Swedish, Danish and Norwegian cohorts. RMD Open. 2023;9(3):e003027. doi:10.1136/rmdopen-2023-003027; Smolen JS, Aletaha D, Barton A, Burmester GR, Emery P, Firestein GS, et al. Rheumatoid arthritis. Nat Rev Dis Primers. 2018;4: 18001.doi:10.1038/nrdp.2018.1; Sarzi-Puttini P, Zen M, Arru F, Giorgi V, Choy EA. Residual pain in rheumatoid arthritis: Is it a real problem? Autoimmun Rev. 2023;22(11):103423. doi:10.1016/j.autrev.2023.103423; Takanashi S, Kaneko Y, Takeuchi T. Characteristics of patients with difficult-to-treat rheumatoid arthritis in clinical practice. Rheumatology (Oxford). 2021;60(11):5247-5256. doi:10.1093/rheumatology/keab209; Lee YC, Bingham CO 3rd, Edwards RR, Marder W, Phillips K, Bolster MB, et al. Association between pain sensitization and disease activity in patients with rheumatoid arthritis: A cross-sectional study. Arthritis Care Res (Hoboken). 2018;70(2):197-204. doi:10.1002/acr.23266; Jansen N, Ten Klooster PM, Vonkeman HE, van den Berg B, Buitenweg JR. Further evaluation of inflammatory and noninflammatory aspects of pain in rheumatoid arthritis patients. Rheumatol Adv Pract. 2023;7(3):rkad076. doi:10.1093/rap/rkad076; Roodenrijs NMT, van der Goes MC, Welsing PMJ, Tekstra J, Lafeber FPJG, Jacobs JWG, et al. Difficult-to-treat rheumatoid arthritis: Contributing factors and burden of disease. Rheumatology (Oxford). 2021;60(8):3778-3788. doi:10.1093/rheumatology/keaa860; Bertsias A, Flouri ID, Repa A, Avgoustidis N, Kalogiannaki E, Pitsigavdaki S, et al. Patterns of comorbidities differentially affect long-term functional evolution and disease activity in patients with ‘difficult to treat’ rheumatoid arthritis. RMD Open. 2024;10(1):e003808. doi:10.1136/rmdopen-2023-003808; Conran C, Kolfenbach J, Kuhn K, Striebich C, Moreland L. A review of difficult-to-treat rheumatoid arthritis: Definition, clinical presentation, and management. Curr Rheumatol Rep. 2023; 25(12):285-294. doi:10.1007/s11926-023-01117-6; Потапова АС, Каратеев АЕ, Полищук ЕЮ, Матьянова ЕВ, Паневин ТС, Семашко АС, и др. Особенности клинических проявлений ревматоидного артрита у пациентов с недостаточной эффективностью базисных противовоспалительных препаратов в зависимости от наличия признаков центральной сенситизации. Научно-практическая ревматология. 2023;61(2):214-219.; Есин ОР, Горобец ЕА, Хайруллин ИХ, Есин РГ, Гамирова РГ, Шамсутдинова РФ, и др. Опросник центральной сенситизации – русскоязычная версия. Журнал неврологии и психиатрии им. С.С. Корсакова. 2020;120(6):51‑56.; Данилов АБ, Давыдов ОС. Новые возможности диагностики нейропатической боли с помощью анкетных методов. Справочник поликлинического врача. 2008;5:40-44.; Freynhagen R, Baron R, Gockel U, Tolle T. PainDETECT: A new screening questionnaire to detect neropathic components in patients with back pain. Curr Med Res Opin. 2006;22:1911-1920.; Rifbjerg-Madsen S, Christensen AW, Christensen R, Hetland ML, Bliddal H, Kristensen LE, et al. Pain and pain mechanisms in patients with inflammatory arthritis: A Danish nationwide crosssectional DANBIO registry survey. PLoS One. 2017;12(7):e0180014. doi:10.1371/journal.pone.0180014; Tubach F, Ravaud P, Martin-Mola E, Awada H, Bellamy N, Bombardier C, et al. Minimum clinically important improvement and patient acceptable symptom state in pain and function in rheumatoid arthritis, ankylosing spondylitis, chronic back pain, hand osteoarthritis, and hip and knee osteoarthritis: Results from a prospective multinational study. Arthritis Care Res (Hoboken). 2012;64(11):1699-1707. doi:10.1002/acr.21747; Heisler AC, Song J, Muhammad LN, Wohlfahrt A, Marder W, Bolster MB, et al. Association of dysregulated central pain processing and response to disease-modifying antirheumatic drug therapy in rheumatoid arthritis. Arthritis Rheumatol. 2020;72(12):2017-2024. doi:10.1002/art.41440; Ten Klooster PM, de Graaf N, Vonkeman HE. Association between pain phenotype and disease activity in rheumatoid arthritis patients: A non-interventional, longitudinal cohort study. Arthritis Res Ther. 2019;21(1):257. doi:10.1186/s13075-019-2042-4; Saitou M, Noda K, Matsushita T, Ukichi T, Kurosaka D. Central sensitisation features are associated with neuropathic pain-like symptoms in patients with longstanding rheumatoid arthritis: A cross-sectional study using the central sensitisation inventory. Clin Exp Rheumatol. 2022;40(5):980-987. doi:10.55563/clinexprheumatol/msy022; Adami G, Gerratana E, Atzeni F, Benini C, Vantaggiato E, Rotta D, et al. Is central sensitization an important determinant of functional disability in patients with chronic inflammatory arthritides? Ther Adv Musculoskelet Dis. 2021;13:1759720X21993252. doi:10.1177/1759720X21993252; Guler MA, Celik OF, Ayhan FF. The important role of central sensitization in chronic musculoskeletal pain seen in different rheumatic diseases. Clin Rheumatol. 2020;39(1):269-274. doi:10.1007/s10067-019-04749-1; Noda K, Saitou M, Matsushita T, Ukichi T, Kurosaka D. How do central sensitisation features affect symptoms among patients with rheumatoid arthritis? Analysis of pain descriptors and the effect of central sensitivity syndrome on patient and evaluator global assessments. Clin Exp Rheumatol. 2022;40(11):2119-2124. doi:10.55563/clinexprheumatol/nyxvyu; Dougados M, Perrot S. Fibromyalgia and central sensitization in chronic inflammatory joint diseases. Joint Bone Spine. 2017;84(5):511-513. doi:10.1016/j.jbspin.2017.03.001; Heiberg T, Kvien TK, Mowinckel P, Aletaha D, Smolen JS, Hagen KB. Identification of disease activity and health status cut-off points for the symptom state acceptable to patients with rheumatoid arthritis. Ann Rheum Dis. 2008;67(7):967-971. doi:10.1136/ard.2007.077503; Nowell WB, Gavigan K, Kannowski CL, Cai Z, Hunter T, Venkatachalam S, et al. Which patient-reported outcomes do rheumatology patients find important to track digitally? A real-world longitudinal study in ArthritisPower. Arthritis Res Ther. 2021;23(1):53. doi:10.1186/s13075-021-02430-0; Fautrel B, Alten R, Kirkham B, de la Torre I, Durand F, Barry J, et al. Call for action: How to improve use of patient-reported outcomes to guide clinical decision making in rheumatoid arthritis. Rheumatol Int. 2018;38(6):935-947. doi:10.1007/s00296-018-4005-5; Uhrenholt L, Christensen R, Dreyer L, Schlemmer A, Hauge EM, Krogh NS, et al. Using a novel smartphone application for capturing of patient-reported outcome measures among patients with inflammatory arthritis: A randomized, crossover, agreement study. Scand J Rheumatol. 2022;51(1):25-33. doi:10.1080/03009742.2021.1907925

الاتاحة: https://rsp.mediar-press.net/rsp/article/view/3640
https://doi.org/10.47360/1995-4484-2024-535-541

المؤلفون: Rvachev, A. L., Sholkina, M. V.

المصدر: Russian Physics Journal; May 1975, Vol. 18 Issue: 5 p743-745, 3p